What Is the Aldosterone Renin Ratio (ARR)?
The aldosterone-renin ratio is one of the most widely used first-line screening tests for primary aldosteronism, a common and potentially treatable cause of secondary hypertension. ARR combines two biologically linked measurements: plasma aldosterone concentration (PAC) and renin. In many laboratories, renin is reported either as plasma renin activity (PRA) or direct renin concentration (DRC). The ratio is calculated by dividing aldosterone by renin after proper unit standardization.
The clinical logic is straightforward. In primary aldosteronism, aldosterone secretion is relatively autonomous and renin tends to be suppressed. This creates a pattern where aldosterone is inappropriately elevated relative to renin, leading to a high ARR. A high ratio does not confirm diagnosis by itself, but it identifies patients who may benefit from confirmatory testing and subtype evaluation.
Because ARR performance is highly dependent on laboratory methodology and patient preparation, this calculator emphasizes both the numeric result and context. The number alone is useful; the number plus specimen conditions, potassium, sodium status, and medication profile is far more useful.
Why an ARR Calculator Is Helpful in Real Practice
ARR can be deceptively simple mathematically but clinically complex operationally. Different labs report different units, and clinicians frequently need quick conversion support. A digital calculator reduces arithmetic errors and makes assumptions explicit. This page converts aldosterone and renin into a standardized frame and provides an interpretation band aligned with commonly used PRA-based thresholds.
- Standardizes aldosterone entered in ng/dL or pmol/L.
- Accepts renin as PRA or DRC.
- Allows customizable DRC-to-PRA conversion factor when applicable.
- Lets you adjust ARR cutoff for local protocol.
- Flags possible pre-analytic and medication confounders.
The result is a fast, reproducible calculation that supports screening workflows in hypertension clinics, endocrine practices, and primary care triage pathways.
Patient Preparation Before ARR Testing
Pre-test preparation has a major impact on ARR reliability. Even a technically correct ratio can mislead if conditions are suboptimal. Institutions differ, but common principles include correction of hypokalemia, consideration of sodium intake, and review of drugs that alter renin or aldosterone levels.
Common preparation elements
- Correct low potassium before testing when possible.
- Use standardized posture and timing (seated, upright, or morning protocol depending on local policy).
- Review antihypertensive medications and endocrine therapies for interference.
- Avoid interpreting borderline values without clinical context.
- Repeat testing if collection conditions were inconsistent.
Medication management should be individualized and clinically safe. In many patients, complete washout is not practical, and interpretation must account for likely directional effects on renin and aldosterone.
How to Interpret ARR Results
In many PRA-based algorithms, ARR values around 20 to 30 are considered a gray zone, and values at or above 30 often trigger further workup when supported by adequate aldosterone levels and compatible clinical findings. Some centers use different cutoffs based on assay characteristics and whether renin is measured by PRA or DRC.
Clinicians should avoid over-interpreting one ratio without looking at absolute values. A very low renin can inflate ARR even when aldosterone is not convincingly elevated. Conversely, high renin states can mask an abnormal aldosterone signal. The most useful interpretation integrates:
- ARR magnitude
- Absolute aldosterone concentration
- Renin suppression pattern
- Potassium level and metabolic profile
- Blood pressure phenotype and cardiovascular risk
- Medication and collection conditions
A positive screening result usually leads to confirmatory testing according to local pathways, followed by subtype evaluation where appropriate.
Common Clinical Scenarios Where ARR Screening Matters
- Resistant hypertension requiring multiple antihypertensive agents.
- Hypertension with spontaneous or diuretic-induced hypokalemia.
- Early-onset or severe hypertension.
- Adrenal incidentaloma with hypertension.
- Family history suggesting inherited mineralocorticoid excess patterns.
Earlier identification of primary aldosteronism may improve blood pressure control and reduce long-term cardiovascular and renal risk when targeted therapy is provided.
ARR Limitations You Should Know
No single ARR threshold is universally correct. Assay method, specimen handling, local reference ranges, and unit systems all matter. DRC-based programs may use center-specific thresholds that do not map perfectly to PRA-based cutoffs. Conversion factors are useful approximations but not substitutes for direct lab validation.
ARR is a screening test, not a standalone diagnosis. A high ratio should generally be treated as a prompt for structured confirmation and clinical correlation. A normal ratio does not completely exclude disease in every context, especially if strong clinical suspicion remains.
Detailed Step-by-Step: Using This Aldosterone Renin Ratio Calculator
- Enter aldosterone value and select the correct unit from your report.
- Select renin assay type (PRA or DRC).
- Enter renin value; if DRC is selected, verify the conversion factor used by your local lab or pathway.
- Set your preferred positive ARR cutoff if different from default.
- Optionally add potassium and mark potential confounders.
- Click calculate and review both numeric result and interpretation text.
- Use result to support next-step planning, not as an isolated diagnosis.
Clinical Follow-Up After a Positive Screening ARR
If screening is suggestive and clinical probability is meaningful, many pathways proceed to confirmatory suppression testing and then subtype workup when indicated. Decisions are individualized, and the practical sequence depends on local expertise, test availability, and patient factors such as comorbidity and blood pressure stability.
Patients with confirmed disease may be managed medically with mineralocorticoid receptor antagonists or evaluated for targeted procedural options in selected unilateral forms. Shared decision-making, safety monitoring, and longitudinal blood pressure and potassium review are essential.
Frequently Asked Questions
What is a normal aldosterone renin ratio?
There is no single universal normal value. Many PRA-based screening programs use thresholds around 20 to 30, but interpretation depends on assay method, unit conventions, posture, sodium status, and medications.
Can I use DRC values directly in ARR?
Some centers use DRC-specific cutoffs directly. This calculator offers DRC support with a configurable conversion factor to approximate PRA-style interpretation, but local laboratory guidance should always take priority.
Does hypokalemia affect ARR?
Yes. Low potassium can suppress aldosterone and potentially mask biochemical patterns. Correcting potassium prior to screening is often recommended when feasible and safe.
Do blood pressure medications change ARR?
Many do. ACE inhibitors, ARBs, diuretics, beta blockers, and mineralocorticoid receptor antagonists can alter renin and aldosterone dynamics. Interpretation should account for medication context and local testing protocol.
Is a high ARR diagnostic for primary aldosteronism?
Usually no. A high ARR is generally a positive screening signal, not final confirmation. Confirmatory testing and specialist evaluation are commonly required.